Short answer · Medically reviewed summary · Last updated: 2026-04-07
Paramyotonia congenita is classified under the ICD-10-CM code G71.11 (Myotonia congenita), while in the older ICD-9-CM classification system, it was categorized under 359.21 (Myotonia congenita). Because Paramyotonia congenita is a distinct clinical entity within the broader spectrum of non-dystrophic myotonias, these codes are often used for billing and administrative tracking of the condition globally. What is the clinical nature of Paramyotonia congenita? Paramyotonia congenita is a rare, autosomal dominant skeletal muscle disorder characterized by paradoxical myotonia—meaning muscle stiffness that worsens with exercise rather than improving.
Paramyotonia congenita is classified under the ICD-10-CM code G71.11 (Myotonia congenita), while in the older ICD-9-CM classification system, it was categorized under 359.21 (Myotonia congenita). Because Paramyotonia congenita is a distinct clinical entity within the broader spectrum of non-dystrophic myotonias, these codes are often used for billing and administrative tracking of the condition globally.
Paramyotonia congenita is a rare, autosomal dominant skeletal muscle disorder characterized by paradoxical myotonia—meaning muscle stiffness that worsens with exercise rather than improving. Unlike other forms of myotonia, the stiffness in Paramyotonia congenita is often triggered or exacerbated by exposure to cold temperatures. Symptoms typically manifest in the first decade of life and primarily affect the muscles of the face, eyelids, neck, and hands. Our community at DiseaseMaps.org currently supports 82 individuals living with Paramyotonia congenita, many of whom report that managing these cold-induced episodes is a primary focus of their daily self-care routines.
Diagnosis of Paramyotonia congenita is primarily clinical, based on the presence of cold-induced muscle stiffness and the failure of repetitive exercise to resolve the myotonia. To confirm the diagnosis and distinguish it from other ion channelopathies, clinicians rely on:
Yes, Paramyotonia congenita follows an autosomal dominant pattern of inheritance. This means that an affected individual has a 50% chance of passing the pathogenic SCN4A mutation to each of their children. Because the clinical severity of Paramyotonia congenita can vary significantly even within the same family (variable expressivity), it is essential for families to consult with a clinical geneticist to understand the specific risks and to discuss family planning options.
Management of Paramyotonia congenita is largely symptomatic. Avoiding known triggers, particularly cold exposure, is the most effective way to prevent the hallmark paradoxical myotonia. In some cases, medications such as mexiletine are prescribed to help stabilize the muscle membrane and reduce the frequency and severity of myotonic episodes. Because this is a rare condition, finding a neurologist or neuromuscular specialist familiar with ion channelopathies is vital for developing a personalized treatment plan.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.